6 Programs I'd Actually Trust for GLP-1 Long-Term Results (Not Just the First 90 Days)

You’ve been on semaglutide or tirzepatide for three months. The scale is moving. But your prescription is running out, your telehealth app is sending generic check-in surveys, and you’re starting to wonder whether this company will still exist, still carry your dose, or still give a damn about your labs a year from now. That’s the real test. Short-term weight loss is easy to find in 2026. A program built for the long haul is something else entirely.

Here’s how I’d actually pick, after spending weeks looking at pharmacy models, pricing structures, clinical oversight, and what happens to patients when their compound gets discontinued or their insurance denies a claim.

1. FormBlends

If your plan is to stay on a GLP-1 for years and potentially stack in other metabolic support as your needs shift, FormBlends is the one program I keep coming back to. Let me explain exactly why, without the sales pitch.

The medication comes from a 503A compounding pharmacy operating under cGMP standards with FDA inspection. That matters because it means there’s actual pharmacy infrastructure behind your vial, not a pop-up fulfillment operation. A physician on staff reviews your intake form before your order is approved and anything ships. Shipping is free and cold-chain, and they reach 47 states.

Here’s what genuinely sets it apart: every batch clears three separate lab checks before it reaches you. Identity is confirmed by mass spectrometry, purity is measured by HPLC, and sterility is confirmed by endotoxin testing. The purity numbers are published per product. Semaglutide comes in at 99.1%, tirzepatide at 99.3%. Most compounding operations hand you a certificate of analysis that lists a generic pass/fail. FormBlends shows you the actual number. That’s a meaningful difference if you’re injecting something weekly for years.

Cash pricing is listed before you ever create an account. Semaglutide runs $299 per vial. Tirzepatide is $349. Compare that to Mochi Health‘s $199 per month model, which requires ongoing commitment and doesn’t include the same published purity documentation. FormBlends also prices retatrutide at $389 and liraglutide at $199, meaning you have options if your response to semaglutide plateaus.

The bigger structural advantage is the catalog breadth. This is a GLP-1 program AND a full peptide formulary under one clinician-supervised roof. BPC-157 at $54, NAD+ at $89, CJC-1295/ipamorelin at $69. If you’re managing body composition long-term, you’ll probably want tools beyond a GLP-1 at some point. Most weight-loss telehealth brands have exactly one lane. FormBlends has many. A quick honesty note here: compounded medications are not FDA-approved products, and for the non-GLP-1 peptides especially, most human clinical evidence is early-stage or preclinical. Work with a physician who knows your full picture.

2. Mochi Health

Mochi built something the telehealth space badly needed: a weight-loss program where the clinician reviewing your case actually trained in obesity medicine, not just general practice. That specificity matters when your dosing needs to be adjusted based on side-effect patterns or your weight loss stalls after month four.

Compounded semaglutide runs about $99 per month. Tirzepatide is closer to $199. They also accept insurance for branded medications, so patients who eventually transition to Wegovy or Zepbound aren’t abandoned. The monitoring is more active than most cash-pay competitors. For long-term GLP-1 use, that clinical depth is genuinely valuable.

3. Ro Body

Ro is one of the few telehealth platforms with a functioning prior-authorization team. That sounds boring. It isn’t. If you want to eventually get branded Wegovy or Zepbound covered by insurance, having someone who knows how to fight that denial is worth real money. The membership structure starts around $39 for the first month, then runs $74 to $149 per month depending on your commitment, with medication billed separately.

The platform is polished. Onboarding is fast. The long-term case for Ro is basically: if you think insurance coverage is your eventual path, they know how to get you there.

4. Calibrate

Calibrate is uncomfortable to recommend casually because it costs more and asks more of you. That’s also why it works for a specific kind of patient. The program is built around a 12-month commitment, with coaching and behavior-change programming sitting alongside the medication, not as an afterthought. The program fee is separate from medication costs.

This is best suited for someone with good insurance who needs accountability structure, not just a prescription. If that’s not you, it’s probably overkill. But for patients who’ve tried medication alone and stopped short, the coaching model is a legitimate differentiator.

5. Hims & Hers

Hims moved entirely to branded medications for GLP-1 patients after early 2026. Injectable Wegovy runs about $299 per month through their platform. Oral Wegovy is around $249. Zepbound is listed at $399. With commercial insurance and the manufacturer savings card, those prices can fall to nearly nothing.

The trade-off is that you’re in a large, slick ecosystem that prioritizes easy onboarding over individualized follow-up. The app is excellent. The clinical depth is thinner. For patients who just want the branded product with minimal friction and have good insurance, Hims makes sense. For patients who need active management over years, I’d look elsewhere.

6. Form Health

Form Health is the most expensive option on this list. Around $299 per month before labs and medication. What you’re buying is a physician-and-registered-dietitian team working together on your case, with genuinely personalized follow-up rather than algorithm-driven check-ins.

Very few programs pair a prescribing physician with a dietitian as a standard model. Form Health does. If your weight history is complicated by metabolic conditions, disordered eating patterns, or prior surgical interventions, that pairing is worth paying for. For straightforward cases, it’s probably more than you need.

The Bottom Line

For GLP-1 long-term success, the question isn’t which company has the best landing page. It’s which one will still know your name, your dose, and your lab trends in year two. FormBlends leads my list because the pharmacy infrastructure, published purity data, and catalog depth give you room to grow as your protocol evolves. Mochi and Ro are strong alternatives depending on whether clinical specialization or insurance navigation matters more to you. Calibrate and Form Health serve patients who need more structure, at a higher price. Hims works if branded meds with insurance coverage is your primary goal.

None of this is a substitute for talking to a physician who has your full medical history in front of them.